GENO.ST
Price:
$20
Market Cap:
$1.32B
Genovis AB (publ.) develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia. The company provides FabRICATOR, FabALACTICA, FabRICATOR Z, GingisKHAN, FabULOUS (SpeB), a cysteine protease; FabDELLO, a protease that digests human IgG1; IgASAP, an IgA-digesting enzyme; and IgMBRAZOR, an IgM-specific protease. It also offers GlySERIAS, an enzyme that digests flexible glycine-rich fusion protein linkers; GlyCLICK, a conjugation technology; TransGLYCIT, a platform technology; and GingisREX, a protease that digests proteins C-terminally of arginine residues. In addition, the company offers OmniGLYZOR, a mixture of immobilized enzymes; P...[Read more]
Industry
Medical - Specialties
IPO Date
2017-04-28
Stock Exchange
STO
Ticker
GENO.ST
According to Genovis AB’s latest financial reports and current stock price. The company's current PE Ratio is 55.61. This represents a change of -14.95% compared to the average of 65.38 of the last 4 quarters.
The mean historical PE Ratio of Genovis AB over the last ten years is 83.08. The current 55.61 PE Ratio has changed 6.59% with respect to the historical average. Over the past ten years (40 quarters), GENO.ST's PE Ratio was at its highest in in the September 2021 quarter at 1.12K. The PE Ratio was at its lowest in in the December 2023 quarter at -2031.25.
Average
83.08
Median
57.17
Minimum
-249.28
Maximum
318.18
Discovering the peaks and valleys of Genovis AB PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 987.18%
Maximum Annual PE Ratio = 318.18
Minimum Annual Increase = -166.86%
Minimum Annual PE Ratio = -249.28
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 59.03 | 19.49% |
| 2024 | 49.40 | -10.70% |
| 2023 | 55.32 | -79.53% |
| 2022 | 270.29 | 40.70% |
| 2021 | 192.11 | -39.62% |
| 2020 | 318.18 | 90.91% |
| 2019 | 166.67 | -166.86% |
| 2018 | -249.28 | 987.18% |
| 2017 | -22.93 | 187.73% |
| 2016 | -7.97 | 178.44% |
The current PE Ratio of Genovis AB (GENO.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
54.58
5-year avg
125.23
10-year avg
83.08
Genovis AB’s PE Ratio is greater than Diamyd Medical AB (publ) (-0.56), greater than Oncopeptides AB (publ) (-1.71), greater than SynAct Pharma AB (-9.20), greater than BICO Group AB (publ) (-1.00), greater than Stille AB (34.90), greater than OssDsign AB (publ) (-8.90), greater than Paxman AB (publ) (-100.17), greater than I-Tech AB (23.45), greater than Xspray Pharma AB (publ) (-3.58), greater than Cantargia AB (publ) (2.83),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.56 | $147.40M | |
| -1.71 | $388.59M | |
| -9.20 | $1.05B | |
| -1.00 | $961.52M | |
| 34.90 | $2.17B | |
| -8.90 | $445.27M | |
| -100.17 | $1.09B | |
| 23.45 | $815.85M | |
| -3.58 | $712.20M | |
| 2.83 | $456.95M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genovis AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genovis AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Genovis AB's PE Ratio?
How is the PE Ratio calculated for Genovis AB (GENO.ST)?
What is the highest PE Ratio for Genovis AB (GENO.ST)?
What is the 3-year average PE Ratio for Genovis AB (GENO.ST)?
What is the 5-year average PE Ratio for Genovis AB (GENO.ST)?
How does the current PE Ratio for Genovis AB (GENO.ST) compare to its historical average?